Literature DB >> 6179611

Growth state-specific responsiveness of primary cultures of a nude mouse-xenografted human colon carcinoma to 4'-deoxydoxorubicin and a crude human leukocyte alpha-interferon preparation.

J van der Bosch, K A Zirvi.   

Abstract

Improved procedures for the seeding of primary cultures from human colon tumors are described. Responsiveness of primary cultures from human colon carcinoma T348 to a crude preparation of human leukocyte alpha-interferon and a DNA-intercalating experimental anticancer drug, 4'-deoxydoxorubicin, has been investigated. The effect of the interferon preparation on such cultures is shown to be growth state specific; i.e., stationary populations are killed, whereas fast-growing cultures are reversibly growth inhibited by the same doses of interferon. In contrast, 4'-deoxydoxorubicin kills growing populations, whereas stationary cultures are barely affected by the same concentration of this drug. Interferon antagonizes the cytotoxic effect of 4'-deoxydoxorubicin on a growing colon tumor cell population when applied immediately after 4'-deoxydoxorubicin treatment. Implications of this finding for the combined application of several drugs in cancer therapy are discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6179611

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

1.  A rapid and simple procedure for dissociation of tumor tissue from the human colon.

Authors:  W Kemmner; P Schlag; R Brossmer
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

2.  Activity of cancer chemotherapeutic agents against human colorectal carcinomas grown as primary tissue culture.

Authors:  K A Zirvi; J van der Bosch; H Masui; N O Kaplan; G J Hill
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

3.  No synergistic activity of epirubicin and interferon-alpha 2b in the treatment of hepatocellular carcinoma.

Authors:  C Bokemeyer; B Kynast; A Harstrick; E Laage; E Schmoll; P von Wussow; H J Schmoll
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

4.  Response of differentiated but not anaplastic teratoma to interferon.

Authors:  G J Rustin; S B Kaye; C J Williams; E S Newlands; K D Bagshawe; J L Toy
Journal:  Br J Cancer       Date:  1984-11       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.